# TaoWeave, Inc.: overview TWAV · Nasdaq · CIK 746210 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/twav.md) · [Financials](/companies/twav/financials.md) · [Filings](/companies/twav/filings.md) · [Insiders](/companies/twav/insiders.md) Latest reported revenue: [$522.0k](/filings/0001437749-26-026577.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001437749-26-026577). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [578](/filings/0001437749-25-034612.md) | [563 d](/filings/0001437749-26-009237.md) | [622](/filings/0001437749-26-017382.md) | [592](/filings/0001437749-26-026577.md) | [601](/filings/0001437749-25-034612.md) | [622 d](/filings/0001437749-26-009237.md) | [707](/filings/0001437749-26-017382.md) | [522](/filings/0001437749-26-026577.md) | | Gross margin | % | [13.7%](/filings/0001437749-25-034612.md) | [24.0% d](/filings/0001437749-26-009237.md) | [40.0%](/filings/0001437749-26-017382.md) | [38.5%](/filings/0001437749-26-026577.md) | [40.6%](/filings/0001437749-25-034612.md) | [47.3% d](/filings/0001437749-26-009237.md) | [66.5%](/filings/0001437749-26-017382.md) | [52.5%](/filings/0001437749-26-026577.md) | | Operating margin | % | [(185.5%)](/filings/0001437749-25-034612.md) | [(164.8%) d](/filings/0001437749-26-009237.md) | [(111.1%)](/filings/0001437749-26-017382.md) | [(115.4%)](/filings/0001437749-26-026577.md) | [(133.4%)](/filings/0001437749-25-034612.md) | [(126.2%) d](/filings/0001437749-26-009237.md) | [(79.1%)](/filings/0001437749-26-017382.md) | [(161.1%)](/filings/0001437749-26-026577.md) | | Net margin | % | [(179.9%)](/filings/0001437749-25-034612.md) | [(157.0%) d](/filings/0001437749-26-009237.md) | [(108.0%)](/filings/0001437749-26-026577.md) | [(102.2%)](/filings/0001437749-26-026577.md) | [(381.0%)](/filings/0001437749-25-034612.md) | [(448.2%) d](/filings/0001437749-26-009237.md) | [240.0%](/filings/0001437749-26-026577.md) | [(630.3%)](/filings/0001437749-26-026577.md) | | Diluted EPS | $ per share | not reported | not reported | [(0.59)](/filings/0001437749-26-017382.md) | not reported | not reported | not reported | [0.43](/filings/0001437749-26-017382.md) | not reported | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [7,739](/filings/0000746210-23-000011.md) | [5,476](/filings/0000746210-24-000009.md) | [3,810](/filings/0001437749-25-008262.md) | [2,378](/filings/0001437749-26-009237.md) | [2,437](/filings/0001437749-26-009237.md) | | Gross margin | % | [35.1%](/filings/0000746210-23-000011.md) | [28.2%](/filings/0000746210-24-000009.md) | [23.9%](/filings/0001437749-25-008262.md) | [13.9%](/filings/0001437749-26-009237.md) | [41.6%](/filings/0001437749-26-009237.md) | | Operating margin | % | [(152.4%)](/filings/0000746210-23-000011.md) | [(401.5%)](/filings/0000746210-24-000009.md) | [(118.0%)](/filings/0001437749-25-008262.md) | [(176.7%)](/filings/0001437749-26-009237.md) | [(121.5%)](/filings/0001437749-26-009237.md) | | Net margin | % | [(117.0%)](/filings/0000746210-23-000011.md) | [(400.7%)](/filings/0000746210-24-000009.md) | [(115.1%)](/filings/0001437749-25-008262.md) | [(170.0%)](/filings/0001437749-26-009237.md) | [(260.8%)](/filings/0001437749-26-009237.md) | | Diluted EPS | $ per share | [(5.48)](/filings/0000746210-23-000011.md) | [(10.62)](/filings/0000746210-24-000009.md) | [(0.98)](/filings/0000746210-24-000009.md) | not reported | not reported | | Free cash flow | $k | [(7,782)](/filings/0000746210-23-000011.md) | [(5,945)](/filings/0000746210-24-000009.md) | [(2,993)](/filings/0001437749-25-008262.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/twav/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $57.9k | 41,990 | | New +41,990 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $51.4k | 37,237 | | New +37,237 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $42.5k | 30,782 | | Reduced −61,205 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $29.5k | 21,400 | | Reduced −38,000 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $25.5k | 18,472 | | Unchanged | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $17.1k | 12,361 | | New +12,361 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $14.9k | 10,822 | | Unchanged | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $6.2k | 4,479 | | Added +4,472 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $5.9k | 4,273 | | New +4,273 | | [NewEdge Advisors, LLC](/funds/1633516.md) | 2026-06-30 | $71 | 50 | | New +50 | ## Recent filings [All 662 filings](/companies/twav/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-07 | 12:35 ET | [8-K](/filings/0001437749-26-032268.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032268 | | 2026-08-07 | 20:06 ET | [10-Q](/filings/0001437749-26-026577.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026577 | | 2026-06-17 | 13:05 ET | [8-K](/filings/0001437749-26-020863.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-020863 | | 2026-06-03 | 20:10 ET | [8-K](/filings/0001437749-26-019366.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-019366 | | 2026-05-18 | 20:05 ET | [8-K](/filings/0001437749-26-017605.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017605 | | 2026-05-15 | 20:16 ET | [10-Q](/filings/0001437749-26-017382.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017382 | | 2026-03-20 | 20:20 ET | [10-K](/filings/0001437749-26-009237.md) | Annual report, period 2025-12-31 | 0001437749-26-009237 | | 2025-12-19 | 21:06 ET | [8-K](/filings/0001437749-25-038437.md) | 5.07 Shareholder vote results | 0001437749-25-038437 | | 2025-12-11 | 13:40 ET | [8-K](/filings/0001437749-25-037490.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037490 | | 2025-12-08 | 14:04 ET | [8-K](/filings/0001437749-25-037088.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-037088 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-009237.md), filed Mar 20, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/1543f5c4-594d-4bae-84b1-1b909a81e3e0) ## About the filer - CIK: 746210 - Tickers: TWAV - Exchange: Nasdaq - SIC code: 7370 Services-Computer Programming, Data Processing, Etc. - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.